SoftOx Solutions
Less than 1K followers
SOFTX
Euronext Growth Oslo
Biotechnology & Pharmaceuticals
Health Care
Overview
Investor consensus
SoftOx Solutions is a Norwegian medical technology company. The company has developed a proprietary solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development is done in collaboration with other research institutes. SoftOx Solutions was founded in 2012 and is headquartered in Oslo, Norway.
Read moreMarket cap
-
Turnover
-
Revenue
7.91M
EBIT %
-410.37 %
P/E
-
Dividend yield-%
-
Financial calendar
25/3
2026
Annual report '25
23/6
2026
General meeting '26
24/6
2026
Interim report Q1'26
All
Press releases
ShowingAll content types
SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)
SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools